SCHEMBL6897108

SCHEMBL6897108

CCCC(CN)CN

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL171318 0.93
Hydrochloric Acid SCHEMBL10764012 0.90 ALDH1A1 (0.50)
SCHEMBL19226754 0.88 ALDH1A1 (0.56)
SCHEMBL28109510 0.87
SCHEMBL637922 0.87
SCHEMBL995550 0.84
SCHEMBL19187626 0.84
SCHEMBL23917937 0.82 ALDH1A1 (0.71)
SCHEMBL4857182 0.82 ALDH1A1 (0.71)
SCHEMBL3851576 0.82

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230203039-A1 MACROCYCLIC PAD4 INHIBITORS USEFUL AS IMMUNOSUPPRESSANT BRISTOL MYERS SQUIBB CO (US) 2023-06-29 US disclosed
US-11312906-B2 Polymerizable monomer, liquid crystal composition using polymerizable monomer, and liquid crystal display device DIC CORPORATION (JP) 2022-04-26 US disclosed
US-20210139730-A1 DISPERSION AND INKJET INK COMPOSITION, LIGHT CONVERSION LAYER, AND LIQUID CRYSTAL DISPLAY ELEMENT USING THE DISPERSION DIC CORPORATION (JP) 2021-05-13 US disclosed
US-10947403-B2 Dispersion and inkjet ink composition, light conversion layer, and liquid crystal display element using the dispersion DIC CORPORATION (JP) 2021-03-16 US disclosed
EP-3730590-A1 LIQUID CRYSTAL MEDIA WITH HOMEOTROPIC ALIGNMENT Merck Patent GmbH (DE) 2020-10-28 EP disclosed
US-20200264461-A1 LIGHT CONVERSION FILM AND IMAGE DISPLAY DEVICE DIC CORPORATION (JP) 2020-08-20 US disclosed
US-20200224098-A1 POLYMERIZABLE MONOMER, LIQUID CRYSTAL COMPOSITION USING POLYMERIZABLE MONOMER, AND LIQUID CRYSTAL DISPLAY DEVICE DIC CORPORATION (JP) 2020-07-16 US disclosed
US-20200208054-A1 LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY ELEMENT DIC Corporation (Tokyo) (JP) 2020-07-02 US disclosed
EP-2918658-B1 Liquid crystalline media with homeotropic alignment MERCK PATENT GMBH (DE) 2020-05-13 EP disclosed
US-10513657-B2 Liquid-crystalline media having homeotropic alignment MERCK PATENT GMBH (DE) 2019-12-24 US disclosed
WO-2016015803-A1 LIQUID CRYSTALLINE MEDIA HAVING HOMEOTROPIC ALIGNMENT MERCK PATENT GMBH (DE) 2016-02-04 WO disclosed
EP-2918658-A2 Liquid crystalline media with homeotropic alignment Merck Patent GmbH (DE) 2015-09-16 EP disclosed
US-20150252265-A1 LIQUID-CRYSTALLINE MEDIA HAVING HOMEOTROPIC ALIGNMENT MERCK PATENT GMBH (DE) 2015-09-10 US disclosed
US-20150252265-A1 LIQUID-CRYSTALLINE MEDIA HAVING HOMEOTROPIC ALIGNMENT MERCK PATENT GMBH (DE) 2015-09-10 US disclosed
US-6818655-B2 2-AMINOQUINOLINES; CARDIOVASCULAR, GASTROINTESTINAL, PYSCHOLOGICAL, RESPIRATORY AND NERVOUS SYSTEM DISORDERS SMITHKLINE BEECHAM CORPORATION 2004-11-16 US disclosed
CN-1097042-C Process for manufacture of aliphatic alpha, omega amino nitriles BASF AG (DE) 2002-12-25 CN disclosed
US-6320051-B1 AMINO(NH) OR OXYGEN(O) SUBSTITUTED, ENZYME INHIBITORS OF STAPHLOCCOCUS AUREUS METHIONYL T-RNA SYNTHETASE (MRS); ANTIBACTERIAL AGENTS SMITHKLINE BEECHAM PLC (GB) 2001-11-20 US disclosed
CN-1237153-A Process for preparing aliphatic alpha, omega-aminonitriles BASF AG (DE) 1999-12-01 CN disclosed
CN-1017803-B ANTI-TUMOR PLATINUM COMPLEX AND PREPARATION THEREOF SANKYO CO (JP) 1992-08-12 CN disclosed
CN-1034544-A Antineoplastic platinum complex, its preparation and therepic use SANKYO CO (JP) 1989-08-09 CN disclosed